Vikas Sinha
President en ALLOVIR, INC. .
Fortuna: 2 M $ al 31/03/2024
Cargos activos de Vikas Sinha
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VERONA PHARMA PLC | Director/Board Member | 12/09/2016 | - |
Independent Dir/Board Member | 12/09/2016 | - | |
ALLOVIR, INC. | Director/Board Member | 01/09/2019 | - |
Director of Finance/CFO | 01/09/2018 | - | |
President | 01/09/2018 | - | |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Director/Board Member | 01/12/2017 | - |
Director of Finance/CFO | 01/12/2017 | - | |
Founder | 01/12/2017 | - | |
The Institute of Chartered Accountants of India | Corporate Officer/Principal | - | - |
LifeEDIT Therapeutics, Inc.
LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing private company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Director/Board Member | - | - |
Historial de carrera de Vikas Sinha
Antiguos cargos conocidos de Vikas Sinha.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BCLS ACQUISITION CORP. | Director/Board Member | 01/10/2020 | 01/12/2022 |
Independent Dir/Board Member | 01/10/2020 | 01/12/2022 | |
ALEXION PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/09/2005 | 12/12/2016 |
Bayer Pharmaceuticals Corp. | Director of Finance/CFO | 01/02/2001 | - |
BAYER AG | Corporate Officer/Principal | 01/06/1994 | - |
░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
Formación de Vikas Sinha.
Asian Institute of Management | Masters Business Admin |
Tribhuvan University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Alemania | 2 |
Japón | 2 |
Operativa
Director of Finance/CFO | 5 |
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Sectorial
Health Technology | 7 |
Consumer Services | 4 |
Finance | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
BAYER AG | Health Technology |
VERONA PHARMA PLC | Health Technology |
ALLOVIR, INC. | Health Technology |
Empresas privadas | 7 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Bayer Pharmaceuticals Corp. | |
Bayer Yakuhin Ltd.
Bayer Yakuhin Ltd. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Bayer Yakuhin Ltd. is a Japanese company that manufactures pharmaceuticals and diagnostic substances. The private company is based in Osaka, Japan. | Health Technology |
ANZ Banking Corp.
ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia. | Finance |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Health Technology |
BCLS Acquisition Corp.
BCLS Acquisition Corp. Financial ConglomeratesFinance BCLS Acquisition Corp. is a blank check company, which engages in seeking a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on August 26, 2020 and is headquartered in Boston, MA. | Finance |
LifeEDIT Therapeutics, Inc.
LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing private company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Commercial Services |
- Bolsa de valores
- Insiders
- Vikas Sinha
- Experiencia